- Home
- NSSC vs NVCR Comparison
NSSC vs NVCR Comparison
Compare NSSC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- NVCR
- Stock Information
- Founded
- NSSC 1969
- NVCR 2000
- Country
- NSSC United States
- NVCR Jersey
- Employees
- NSSC 1070
- NVCR N/A
- Industry
- NSSC Telecommunications Equipment
- NVCR Medical/Dental Instruments
- Sector
- NSSC Telecommunications
- NVCR Health Care
- Exchange
- NSSC Nasdaq
- NVCR Nasdaq
- Market Cap
- NSSC 1.5B
- NVCR 1.8B
- IPO Year
- NSSC N/A
- NVCR 2015
- Fundamental
- Price
- NSSC $39.12
- NVCR $17.49
- Analyst Decision
- NSSC Strong Buy
- NVCR Buy
- Analyst Count
- NSSC 6
- NVCR 5
- Target Price
- NSSC $55.33
- NVCR $26.60
- AVG Volume (30 Days)
- NSSC 350.1K
- NVCR 1.3M
- Earning Date
- NSSC 11-04-2024
- NVCR 10-30-2024
- Dividend Yield
- NSSC 1.27%
- NVCR N/A
- EPS Growth
- NSSC 83.56
- NVCR N/A
- EPS
- NSSC 1.34
- NVCR N/A
- Revenue
- NSSC $188,820,000.00
- NVCR $549,964,000.00
- Revenue This Year
- NSSC $14.19
- NVCR $16.23
- Revenue Next Year
- NSSC $14.67
- NVCR $6.09
- P/E Ratio
- NSSC $29.43
- NVCR N/A
- Revenue Growth
- NSSC 11.07
- NVCR 8.33
- 52 Week Low
- NSSC $17.76
- NVCR $10.87
- 52 Week High
- NSSC $58.09
- NVCR $24.74
- Technical
- Relative Strength Index (RSI)
- NSSC 45.46
- NVCR 43.24
- Support Level
- NSSC $38.53
- NVCR $15.61
- Resistance Level
- NSSC $39.64
- NVCR $17.31
- Average True Range (ATR)
- NSSC 1.11
- NVCR 1.29
- MACD
- NSSC 0.03
- NVCR 0.05
- Stochastic Oscillator
- NSSC 35.31
- NVCR 11.59
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.